Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model

Brain Research

Volumn 1257, Issue , 2009, Pages 1-9

  Gua, Shuting ^a   Huanga, Hai ^a   Bia, Jianqing ^a   Yao, Yuan ^a   Wen, Tieqiao ^a  

^a SHANGHAI UNIVERSITY   (China)

Author keywords

Dopaminergic neuron; Neural stem cell; Neurotrophin 3; Parkinson's disease; Transplantation

Indexed keywords

NEUROTROPHIN 3; OXIDOPAMINE; OXYGENASE; APOMORPHINE; DOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; ANIMAL; ANIMAL BEHAVIOR; CELL CULTURE; CELL MOTION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GENE THERAPY; GENETICS; MAZE TEST; MEDIAL FOREBRAIN BUNDLE; METABOLISM; MOTOR ACTIVITY; NERVE CELL; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; PARKINSONISM; PHYSIOLOGY; STEM CELL; STEM CELL TRANSPLANTATION; VENTRAL TEGMENTUM;

PARKINSONIA; RATTUS;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOPAMINE; GENE THERAPY; MAZE LEARNING; MEDIAL FOREBRAIN BUNDLE; MOTOR ACTIVITY; NERVE DEGENERATION; NEUROGENESIS; NEURONS; NEUROTROPHIN 3; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 63349102689     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.016     Document Type: Article

References (38)

1. Bjorklund, L., Sánchez-Pernaute, R., Chung, S., Andersson, T., Chen, I., McNaught, K., Brownell, A., Jenkins, B., Wahlestedt, C., Kim, K., Isacson, O., 2002. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. U. S. A. 99 (4), 2344-2349.
2. Bothwell, M., 1995. Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18, 223-253.
3. Cenci, M., Lee, C., Björklund, A., 1998. L-dopa-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 10 (8), 2694-2706.
4. Chen, X., Liu, W., Guoyuan, Y., Liu, Z., Smith, S., Calne, D., Chen, S., 2003. Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease. Parkinsonism Relat. Disord. 10 (1), 1-7.
5. Chu, K., Kim, M., Chae, S., Jeong, S., Kang, K., Jung, K., Kim, J., Kim, Y., Kang, L., Kim, S., Yoon, B., 2004. Distribution and in situ proliferation patterns of intravenously injected immortalized human neural stem-like cells in rats with focal cerebral ischemia. Neurosci. Res. 50 (4), 459-465.
6. Coppola, V., Kucera, J., Palko, M., Lyons, W., Fritzsch, B., Tessarollo, L., 2001. Dissection of NT3 functions in vivo by gene replacement strategy. Development 128 (21), 4315-4327.
7. Damon, D., 2008. TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3. Am. J. Physiol., Cell Physiol. 294 (1), C306-C312.
8. Dauer, W., Przedborski, S., 2003. Parkinson's disease: mechanisms and models. Neuron 39 (6), 889-909.
9. Deary, I., Bastin, M., Pattie, A., Clayden, J., Whalley, L., Starr, J., Wardlaw, J., 2006. White matter integrity and cognition in childhood and old age. Neurology 66 (4), 505-512.
10. Ebert, A., Beres, A., Barber, A., Svendsen, C., 2008. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp. Neurol. 209 (1), 213-223.
11. Fiandaca, M., Forsayeth, J., Bankiewicz, K., 2008. Current status of gene therapy trials for Parkinson's disease. Exp. Neurol. 209 (1), 51-57.
12. Freed, C., Greene, P., Breeze, R., Tsai, W., 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344 (10), 710-719.
13. Haeri, M., Sarbaz, Y., Gharibzadeh, S., 2005. Modeling the Parkinson tremor and its treatments. J. Theor. Biol. 236, 311-322.
14. Je, H., Zhou, J., Yang, F., Lu, B., 2005. Distinct mechanisms for neurotrophin-3-induced acute and long-term synaptic potentiation. J. Neurosci. 25 (50), 11719-11729.
15. Je, H., Yang, F., Zhou, J., Lu, B., 2006. Neurotrophin 3 induces structural and functional modification of synapses through distinct molecular mechanisms. J. Cell Biol. 175 (6), 1029-1042.
16. Kuan, W.L.B.R., 2005. New therapeutic approaches to Parkinson's disease including neural transplants. Neurorehabilitation Neural Repair 19 (3), 155-181.
17. Lessmann, V., Gottmann, K., Malcangio, M., 2003. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 69 (5), 341-374.
18. Liu, W., Lu, G., Li, B., Chen, S., 2007. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease. ParkinsonismRelat. Disord. 13 (2), 77-88.
19. Lu, P., Tuszynski, M., 2008. Growth factors and combinatorial therapies for CNS regeneration. Exp. Neurol. 209 (2), 313-320.
20. Lundblad, M., M, M.A., Winkler, C., Kirik, D., Wierup, N., Cenci, M., 2002. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a ratmodel of Parkinson's disease. Eur. J. Neurosci. 15 (1), 120-132.
21. Lundblad, M., Picconi, B., Lindgren, H., Cenci, M., 2004. A model of Ldopa-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 16 (1), 110-123.
22. Mayhall, E., Paffett-Lugassy, N., Zon, L., 2004. The clinical potential of stem cells. Curr. Opin. Cell Biol. 16, 713-720.
23. Mendez, I., Sanchez-Pernaute, R., Cooper, O., Viñuela, A., Ferrari, D., Björklund, L., Dagher, A., Isacson, O., 2005. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128, 1498-1510.
24. Moore, D., West, A., Dawson, V., Dawson, T., 2005. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57-87.
25. O'Keeffe, F., Scott, S., Tyers, P., O'Keeffe, G., Dalley, J., Zufferey, R., Caldwell, M., 2008. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease. Brain 131, 630-641.
26. Ostenfeld, T., Tai, Y., Martin, P., Déglon, N., Aebischer, P., Svendsen, C., 2002. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J. Neurosci. Res. 69 (6), 955-965.
27. Petroske, E., Meredith, G., Callen, S., Totterdell, S., Lau, Y., 2001. Mouse model of Parkinsonism: a comparison between subacute mptp and chronic mptp/probenecid treatment. Neuroscience 106, 589-601.
28. Shimazu, K., Zhao, M., Sakata, K., Akbarian, S., Bates, B., Jaenisch, R., Lu, B., 2006. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. Learn. Mem. 13 (3), 307-315.
29. Snider, W., 1994. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77 (5), 627-638.
30. Tessarollo, L., 1998. Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev. 9 (2), 125-137.
31. Tessarollo, L., Coppola, V., Fritzsch, B., 2004. NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J. Neurosci. 24 (10), 2575-2584.
32. Ulusoy, A., Bjorklund, T., Hermening, S., Kirik, D., 2008. In vivo gene delivery for development of mammalian models for Parkinson's disease. Exp. Neurol. 209 (1), 89-100.
33. Ungerstedt, U., 1971. Post-synaptic supersensitivity after 6-OHDA induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. 82, 69-93.
34. Wang, X., Liu, W., Zhang, Y., Lu, G., Chen, S., 2007. Effect of transplantation of c17.2 cells transfected with interleukin-10 gene on intracerebral immune response in rat model of Parkinson's disease. Neurosci. Lett. 423 (2), 95-99.
35. Yasuhara, T., Matsukawa, N., K, K.H., Yu, G., Xu, L., Maki, M., Kim, S., Borlongan, C., 2006. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J. Neurosci. 26 (48), 12497-12511.
36. Yu, Y., Gu, S., Huang, H., Wen, T., 2007. Combination of bFGF, heparin and laminin induce the generation of dopaminergic neurons from rat neural stem cells both in vitro and in vivo. J. Neurol. Sci. 255 (1-2), 81-86.
37. Zhang, L., Gu, S., Zhao, C., Wen, T., 2007. Combined treatment of neurotrophin-3 gene and neural stem cells is propitious to functional recovery after spinal cord injury. Cell Transplant 16 (5), 475-481.
38. Zhou, L., Baumgartner, B., Hill-Felberg, S., McGowen, L., Shine, H., 2003. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J. Neurosci. 23 (4), 1424-1431.